- Home
- BTAI vs HWH Comparison
BTAI vs HWH Comparison
Compare BTAI & HWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- HWH
- Stock Information
- Founded
- BTAI 2017
- HWH 2021
- Country
- BTAI United States
- HWH United States
- Employees
- BTAI N/A
- HWH N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- HWH Other Pharmaceuticals
- Sector
- BTAI Health Care
- HWH Health Care
- Exchange
- BTAI Nasdaq
- HWH Nasdaq
- Market Cap
- BTAI 8.3M
- HWH 8.1M
- IPO Year
- BTAI 2018
- HWH N/A
- Fundamental
- Price
- BTAI $1.84
- HWH $1.33
- Analyst Decision
- BTAI Buy
- HWH
- Analyst Count
- BTAI 5
- HWH 0
- Target Price
- BTAI $34.60
- HWH N/A
- AVG Volume (30 Days)
- BTAI 294.8K
- HWH 58.4K
- Earning Date
- BTAI 08-05-2025
- HWH 08-11-2025
- Dividend Yield
- BTAI N/A
- HWH N/A
- EPS Growth
- BTAI N/A
- HWH N/A
- EPS
- BTAI N/A
- HWH N/A
- Revenue
- BTAI $1,852,000.00
- HWH $1,262,664.00
- Revenue This Year
- BTAI $5.03
- HWH N/A
- Revenue Next Year
- BTAI $291.01
- HWH N/A
- P/E Ratio
- BTAI N/A
- HWH N/A
- Revenue Growth
- BTAI 5.47
- HWH 37.84
- 52 Week Low
- BTAI $1.17
- HWH $0.90
- 52 Week High
- BTAI $23.04
- HWH $7.20
- Technical
- Relative Strength Index (RSI)
- BTAI 62.90
- HWH 52.31
- Support Level
- BTAI $1.59
- HWH $1.15
- Resistance Level
- BTAI $2.22
- HWH $1.26
- Average True Range (ATR)
- BTAI 0.21
- HWH 0.10
- MACD
- BTAI 0.04
- HWH -0.01
- Stochastic Oscillator
- BTAI 75.00
- HWH 53.33
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About HWH HWH International Inc.
HWH International Inc is and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore.